• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用琼脂糖凝胶和欧洲卫矛凝集素从人血浆中分离功能型或高纯度的C2

Separation of functionally or highly pure C2 from human plasma with Sepharose and a lectin of Euonymus europeus.

作者信息

Schultz D R, Arnold P I

出版信息

Acta Pathol Microbiol Immunol Scand Suppl. 1984;284:59-66.

PMID:6587744
Abstract

A method is described for isolating both functionally and highly pure C2 from normal human serum or plasma. Functionally pure C2 was obtained by a two-step method of ammonium sulfate (AS) fractionation of plasma or serum and chromatography on AH-Sepharose containing a bound lectin of Euonymus europeus. The functionally pure C2 can be isolated in 2 days, and is used routinely as a reagent for functional hemolytic titrations of C3 and C4 in the Clinical Immunology Laboratory. Highly pure C2 was isolated by the two-step fractionation with AS followed by chromatography on CM-cellulose, aged CNBr-activated Sepharose 4B, and AH-Sepharose-lectin. The major difficulty for isolating highly pure C2 was its separation from Factor B of the alternative complement pathway. The yield of C2 varied from 30 to 40 per cent. Following electrophoresis and staining on polyacrylamide gels, the single band was hemolytically active C2.

摘要

本文描述了一种从正常人血清或血浆中分离功能上纯净且高度纯化的C2的方法。通过两步法对血浆或血清进行硫酸铵(AS)分级分离,并在含有欧洲卫矛凝集素的AH-琼脂糖上进行色谱分离,获得功能上纯净的C2。功能上纯净的C2可在2天内分离出来,并在临床免疫实验室中常规用作C3和C4功能溶血滴定的试剂。通过AS两步分级分离,随后在CM-纤维素、老化的溴化氰活化琼脂糖4B和AH-琼脂糖-凝集素上进行色谱分离,获得高度纯化的C2。分离高度纯化的C2的主要困难在于将其与替代补体途径的B因子分离。C2的产率在30%至40%之间。在聚丙烯酰胺凝胶上进行电泳和染色后,单一条带为具有溶血活性的C2。

相似文献

1
Separation of functionally or highly pure C2 from human plasma with Sepharose and a lectin of Euonymus europeus.使用琼脂糖凝胶和欧洲卫矛凝集素从人血浆中分离功能型或高纯度的C2
Acta Pathol Microbiol Immunol Scand Suppl. 1984;284:59-66.
2
Requirement for the alternative pathway as well as C4 and C2 in complement-dependent hemolysis via the lectin pathway.补体依赖的凝集素途径溶血中替代途径以及C4和C2的需求。
J Immunol. 1998 Mar 15;160(6):3006-13.
3
The second component of human complement: detection of two hemolytic forms in plasma by pH variation.人类补体的第二个成分:通过pH变化检测血浆中的两种溶血形式。
Immunobiology. 1988 Mar;176(4-5):374-93. doi: 10.1016/S0171-2985(88)80020-2.
4
Purification of the fourth, second and fifth components of mouse complement.小鼠补体第四、第二和第五成分的纯化
Immunology. 1984 Mar;51(3):493-501.
5
The purification and properties of the second component of human complement.人补体第二成分的纯化及其性质
Biochem J. 1978 Apr 1;171(1):99-107. doi: 10.1042/bj1710099.
6
Role of early lectin pathway activation in the complement-mediated killing of Trypanosoma cruzi.早期凝集素途径激活在补体介导的克氏锥虫杀伤中的作用。
Mol Immunol. 2009 Dec;47(2-3):426-37. doi: 10.1016/j.molimm.2009.08.030. Epub 2009 Sep 27.
7
Expression of functional recombinant von Willebrand factor-A domain from human complement C2: a potential binding site for C4 and CRIT.人补体C2功能性重组血管性血友病因子A结构域的表达:C4和CRIT的潜在结合位点
Biochem J. 2005 Aug 1;389(Pt 3):863-8. doi: 10.1042/BJ20050183.
8
Increased susceptibility of complement factor B/C2 double knockout mice and mannan-binding lectin knockout mice to systemic infection with Candida albicans.补体因子B/C2双敲除小鼠和甘露聚糖结合凝集素敲除小鼠对白色念珠菌全身感染的易感性增加。
Mol Immunol. 2008 Sep;45(15):3934-41. doi: 10.1016/j.molimm.2008.06.021. Epub 2008 Jul 30.
9
Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.经典途径激活的表面调节:绵羊、豚鼠和人红细胞上C2和C3转化酶的形成与调节
J Immunol. 1983 Jul;131(1):403-8.
10
The role of immunoglobulins in alternative complement pathway activation by zymosan. I. Human IgG with specificity for Zymosan enhances alternative pathway activation by zymosan.免疫球蛋白在酵母聚糖激活补体替代途径中的作用。I. 对酵母聚糖具有特异性的人IgG增强酵母聚糖对替代途径的激活作用。
J Immunol. 1981 Jan;126(1):7-10.

引用本文的文献

1
Recombinant human complement component C2 produced in a human cell line restores the classical complement pathway activity in-vitro: an alternative treatment for C2 deficiency diseases.重组人源补体成分 C2 在人细胞系中表达,可恢复体外经典补体途径活性:C2 缺乏症的替代治疗方法。
BMC Immunol. 2010 Aug 20;11:43. doi: 10.1186/1471-2172-11-43.